✦ LIBER ✦

Second-generation BCR-ABL inhibitors for frontline treatment of chronic myeloid leukemia in chronic phase

✍ Scribed by Gianantonio Rosti; Fausto Castagnetti; Gabriele Gugliotta; Francesca Palandri; Michele Baccarani

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second generation inhibitors of BCR-ABL

✍ Weisberg, Ellen; Manley, Paul W.; Cowan-Jacob, Sandra W.; Hochhaus, Andreas; Gri 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 651 KB

Importance of adherence to BCR-ABL tyros

✍ de Almeida, Maria Helena; Fogliatto, Laura; Couto, Dulce 📂 Article 📅 2014 🏛 SciELO 🌐 English ⚖ 170 KB

Evolving treatment strategies for patien

✍ Shami, P J; Deininger, M 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 421 KB

A Critical Review of Trials of First-Lin

✍ Jabbour, Elias; Lipton, Jeffrey H. 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 355 KB

Monitoring BCR-ABL in the treatment of c

✍ Vivian G. Oehler; Jerald P. Radich 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 256 KB

Monitoring bcr-abl by polymerase chain r

✍ Vivian G. Oehler; Jerald P. Radich 📂 Article 📅 2003 🏛 Current Science Inc. 🌐 English ⚖ 619 KB